Cryptic splicing in synaptic and membrane excitability genes links TDP-43 loss to neuronal dysfunction
Top Cited Papers
- 3 June 2026
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 18 (852) , eaeb8517
Abstract
TAR DNA binding protein 43 (TDP-43) pathology is a defining pathological hallmark of multiple neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). A major feature of TDP-43 pathology is its nuclear depletion, leading to the aberrant inclusion of cryptic exons during RNA splicing. STMN2 and UNC13A have emerged as prominent TDP-43 splicing targets, but the broader impact of TDP-43–dependent cryptic splicing on neuronal function remains unclear. Here, we report previously unidentified TDP-43 splicing targets critical for membrane excitability and synaptic function, including KALRN , RAP1GAP , SYT7 , and KCNQ2 . Using human stem cell–derived neurons, we showed that TDP-43 reduction induces cryptic splicing and down-regulation of these genes, resulting in impaired excitability and synaptic transmission. In postmortem brains from patients with FTD, these cryptic splicing events occurred selectively in neurons with TDP-43 pathology. Suppressing individual cryptic splicing events using antisense oligonucleotides partially restored neuronal function, and combined targeting almost fully rescued the synaptic deficit caused by TDP-43 loss. Together, our findings provide evidence that cryptic splicing in these synaptic and membrane excitability genes is not only a downstream marker but instead a direct driver of neuronal dysfunction, establishing a mechanistic link between TDP-43 pathology and neurodegeneration in ALS and FTD.Keywords
Funding Information
- National Institutes of Health (R35NS137159)
- National Institutes of Health (U54NS123743)
- National Institutes of Health (R01AG064690)
- National Institutes of Health (AG019724)
- National Institutes of Health (AG062422)
- National Institutes of Health (AG063911)
- National Institutes of Health (AG057195)
- National Institutes of Health (P50MH132775)
- National Institutes of Health (R01MH071316)
This publication has 59 references indexed in Scilit:
- Analysis of the splicing landscape of the frontal cortex in FTLD-TDP reveals subtype specific patterns and cryptic splicingActa Neuropathologica, 2025
- Cryptic exon detection and transcriptomic changes revealed in single-nuclei RNA sequencing of C9ORF72 patients spanning the ALS-FTD spectrumActa Neuropathologica, 2023
- Hallmarks of neurodegenerative diseasesCell, 2023
- Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral SclerosisJAMA Neurology, 2021
- KALRN: A central regulator of synaptic function and synaptopathiesGene, 2021
- Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE RetrotransposonsCell Reports, 2019
- LRRK2 modifies α-syn pathology and spread in mouse models and human neuronsActa Neuropathologica, 2019
- Neurons selectively targeted in frontotemporal dementia reveal early stage TDP-43 pathobiologyActa Neuropathologica, 2018
- Intrinsic Membrane Hyperexcitability of Amyotrophic Lateral Sclerosis Patient-Derived Motor NeuronsCell Reports, 2014
- TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosisBiochemical and Biophysical Research Communications, 2006